Autolus Therapeutics PLC (NAS:AUTL)
$ 3.26 -0.06 (-1.81%) Market Cap: 867.56 Mil Enterprise Value: 278.69 Mil PE Ratio: 0 PB Ratio: 1.82 GF Score: 58/100

Q1 2021 Autolus Therapeutics PLC Earnings Call Transcript

May 06, 2021 / 12:30PM GMT
Release Date Price: $5.1 (-1.92%)
Operator

Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics First Quarter 2021 Financial Results Conference Call. As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Mr. Andrew Oakley, the company's Chief Financial Officer. Please go ahead.

Andrew J. Oakley
Autolus Therapeutics plc - Senior VP & CFO

Thank you, Rebecca, and good morning or good afternoon, everyone, and thank you for taking part in today's call on the financial results and operational highlights for the first quarter of 2021. I'm Andrew Oakley, the Chief Financial Officer; and with me today is Dr. Christian Itin, our Chief Executive Officer. Before we begin, I would like to remind you that during today's call, our discussion will contain forward-looking statements. All statements other than statements of historical facts on this call are forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot